Possibilities of drug treatment in inflammatory intestinal diseases
Van Hogezand, R.A.; Lamers, C.B.
Nederlands Tijdschrift Voor Geneeskunde 138(51): 2536-2540
1994
ISSN/ISBN: 0028-2162 PMID: 7830801 Document Number: 435771
Document emailed within 1 workday
Related Documents
Díaz Blasco, J.; García Valriberas, R. 1997: Methotrexate in the treatment of inflammatory intestinal diseases Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 89(5): 385-390Ouyang, Q. 2001: Inflammatory intestinal diseases: research, diagnosis and treatment Zhonghua Nei Ke Za Zhi 40(1): 3-5
Malchow, H. 1987: Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid Der Internist 28(1): 14-20
Vyshegurov, I.K.; Anikhovskaia, I.A.; Batmanov, I.E.; Iakovlev, M.I. 2007: Intestinal endotoxin in the pathogenesis of ocular inflammatory diseases and the antiendoxin constituent of its treatment Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 12-14
Busch, J.; Hammer, M.; Brunkhorst, R.; Wagener, P. 1988: Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability Zeitschrift für Rheumatologie 47(3): 156-160
Busch, J.; Hammer, M.; Brunkhorst, R.; Wagener, P. 1988: Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability Zeitschrift für Rheumatologie 47(3): 156-160
Pen'kov, M.A.; Avrushchenko, N.M.; Khristenko, L.A. 1978: Ophthalmic drug films in the treatment of inflammatory diseases of the eyeball Oftalmologicheskii Zhurnal 6: 431-433
Seibold, F.; Wagner, A.C.; Göke, B. 2000: Drug treatment of chronic inflammatory bowel diseases: current status and prospects Schweizerische Medizinische Wochenschrift 130(7): 222-232
Shmorgun, S.S.; Zinchenko, T.V.; Kuz'menko, I.A. 1971: Treatment of chronic inflammatory diseases of the biliary tract in children with the new choleretic drug Stachyren Farmatsevtychnyi Zhurnal 26(6): 48-50
Katsambas, A.; Vareltzidis, A. 1973: Therapeutic action of a new non-steroid drug (bufexamac) in the treatment of inflammatory dermatologic diseases. Double-blind clinical study Bruxelles Medical 53(8): 463-468
Zeitz, M. 1997: New therapeutic possibilities in chronic inflammatory bowel diseases Praxis 86(25-26): 1071-1074
Reinthaler, F.F.; Binder, L.; Bauer, B. 1987: Therapeutic possibilities in diseases caused by intestinal parasites Wiener Medizinische Wochenschrift 137(9): 188-192
Galeazzi, M.; Marcolongo, R. 1993: A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases Drugs under Experimental and Clinical Research 19(3): 107-115
Schneider, W. 1981: Epidemiology of chronic inflammatory intestinal diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(3): Suppl: 228-230
Müller, G. 1987: Eicosanoids in chronic inflammatory intestinal diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 42(2): 37-41
Ribière, S.; Bouhnik, Y. 2014: Management of intestinal complications in inflammatory bowel diseases La Revue du Praticien 64(9): 1249-1255
Bansky, G. 1986: Extraintestinal manifestations in chronic inflammatory intestinal diseases Schweizerische Rundschau für Medizin Praxis 75(11): 303-310
Sigel, A.; Bötticher, R.; Supala, K. 1977: Urologic complications od chronic inflammatory intestinal diseases Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 48(4): 262-266
Kniazev, O.V.; Parfenov, A.I.; Ruchkina, I.N.; Konopliannikova, A.G.; Drozdov, V.N.; Sagynbaeva, V.É; Ivkina, T.I. 2013: New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases Terapevticheskii Arkhiv 85(2): 57-60
McCormack, P.M. 1994: Management of non steroidal anti-inflammatory drug induced gastro-intestinal damage Irish Medical Journal 87(2): 27-28